Causaly raised $60m in Series B to revolutionize biomedical research
Longevity Technology - 17-Jul-2023AI-powered research platform to accelerate the processes in drug discovery and development
Join the club for FREE to access the whole archive and other member benefits.
Co-founder and CEO at Causaly
Yiannis Kiachopoulos is the co-founder and CEO at Causaly. He is a computer scientist and language enthusiast, and has consulted with the world’s largest companies for more than 10 years. He previously worked at Detecon International and Accenture.
Yiannis holds a Bachelor and Master in Computer Science, an MBA from Hong Kong University of Science and Technology and took part in Singularity University’s Future Studies program.
Visit website: https://www.causaly.com/about-causaly#YiannisKiachopoulos
See also: Causaly - AI platform for biomedical research
Details last updated 23-Jul-2023
AI-powered research platform to accelerate the processes in drug discovery and development